乳房切除术后乳房再造时机的重要性:一项ACS-NSQIP分析
基于ACS-NSQIP数据库(2008-2021)纳入21560例肿瘤性乳房再造女性患者,比较植入物与自体组织再造在即刻与延期时机下的并发症。倾向评分加权和多变量分析显示,即刻再造并发症显著多于延期再造(p<0.0001),植入物与自体组织再造均如此,且植入物再造两时机差异更大。作者认为结果并非一概推荐即刻或延期再造,而是有助于医患个体化决策。
要点
- 纳入21560例乳房再造患者,植入物再造11237例(即刻9791例/87%,延期1446例/13%),自体组织再造10323例(即刻8378例/81%,延期1945例/19%)。
- 并发症共3666例(17%):植入物再造即刻1112例/11%、延期64例/4.4%;自体组织再造即刻2073例/25%、延期417例/21%。
- 倾向评分加权分析显示即刻再造并发症显著多于延期再造(p<0.0001),植入物与自体组织再造均如此,植入物再造两时机差异更大。
核心结论
- 在30天时间点,延期乳房再造的并发症发生率显著低于即刻再造,植入物再造与自体组织再造队列均如此。
- 作者认为这些发现并非一概推荐即刻和/或延期乳房再造,而是可能指导外科医生和患者决策,并帮助在逐例评估中细化患者资格。
研究设计与样本
- 回顾性分析ACS-NSQIP数据库(2008-2021年),纳入所有因肿瘤目的接受乳房再造的女性患者。
- 共纳入21560例患者,按技术(植入物再造 vs 自体组织再造)和时机(即刻 vs 延期)分层,结局包括30天死亡率、再手术、(非计划)再入院及外科和内科并发症。
主要发现
- 植入物再造11237例(52%):即刻9791例(87%)、延期1446例(13%);自体组织再造10323例(48%):即刻8378例(81%)、延期1945例(19%)。
- 并发症共3666例(17%):植入物再造即刻1112例(11%)、延期64例(4.4%);自体组织再造即刻2073例(25%)、延期417例(21%)。
- 倾向评分加权分析中,即刻乳房再造与显著多于延期乳房再造的并发症相关(p<0.0001),植入物再造与自体组织再造均如此,植入物再造两时机差异更大。
- 混杂因素调整的多变量分析证实上述结果。
临床怎么用
- 作者认为这些发现并非一概推荐即刻和/或延期乳房再造,而是可能指导外科医生和患者决策,并帮助在逐例评估中细化患者资格。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A variety of breast reconstruction (BR) options are available. The significance of timing on outcomes remains debated. This study aims to compare complications in breast cancer patients undergoing implant-based and autologous BR immediately after mastectomy or at a delayed time point. METHODS: We reviewed the ACS-NSQIP database (2008-2021) to identify all female patients who underwent BR for oncological purposes. Outcomes were stratified by technique (implant-based versus autologous) and timing (immediate versus delayed), and included 30-day mortality, reoperation, (unplanned) readmission, and surgical and medical complications. RESULTS: A total of 21,560 patients were included: 11,237 (52%) implant-based (9791/87% immediate, 1446/13% delayed) and 10,323 (48%) autologous (8378/81% immediate, 1945/19% delayed). Complications occurred in 3666 (17%) patients (implant-based: n = 1112/11% immediate, n = 64/4.4% delayed cohorts; Autologous: n = 2073/25% immediate, n = 417/21% delayed cohorts). In propensity score weighting (PSW) analyses, immediate BR was associated with significantly more complications than delayed BR (p < 0.0001). This was the case for both implant-based and autologous BR, with a greater difference between the two time points noted in implant-based. Confounder-adjusted multivariable analyses confirmed these results. CONCLUSION: At the 30-day time point, delayed BR is associated with significantly lower complication rates than immediate BR, in both the implant-based and autologous cohorts. These findings are not a blanket recommendation in favor of immediate and/or delayed BR. Instead, our insights may guide surgeons and patients in decision-making and help refine patients' eligibility in a case-by-case workup.
引用
- Knoedler S, Kauke-Navarro M, Knoedler L, et al. The significance of timing in breast reconstruction after mastectomy: An ACS-NSQIP analysis. J Plast Reconstr Aesthet Surg. 2023. PMID: 38134626. doi:10.1016/j.bjps.2023.11.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。